Upgrade to SI Premium - Free Trial

CVS Health (CVS) PT Lowered to $84 at Evercore ISI; Keeps 'Buy'

February 9, 2017 12:11 PM
Evercore ISI lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.50) while maintaining a Buy rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles